A Retrospective Non-Randomized Case Study Analysis of Mitomycin-C Efficacy in Patients Undergoing Combined Phacotrabeculectomy at a Tertiary Care Hospital in Salem, India
Abstract
Glaucoma and cataracts, which are major contributors to worldwide blindness, frequently occur together, requiring phacotrabeculectomy as the primary therapeutic approach. This study conducted a retrospective analysis of cases to evaluate the efficacy of Mitomycin-C (0.2mg/ml for 3 min) in phacotrabeculectomy, which is a combination surgical treatment that involves trabeculectomy and phacoemulsification. The study was conducted over six months, from January 2022 to June 2022, in a tertiary care hospital in Salem. An analysis was conducted on the records of 60 patients who underwent phacotrabeculectomy and met the inclusion criteria. The study included 60 patients, with 28 (47%) being men and 32 (53%) being females; of these, 22 (37%) underwent surgery on their right eye, while 38 (63%) underwent surgery on their left. Most patients belonged to the age bracket of 51-65 years. The grading of cataracts identified many forms, such as Nuclear Sclerosis (NS-1: 3%, NS-1 and PSC: 10%, NS-2: 17%, NS-2 and PSC: 23%, NS-3: 7%, PSC: 13%). The most prevalent type, affecting the majority (27%) of the population, was Senile Immature Cataract (SIMC). The average preoperative intraocular pressure was 22.4 ± 1.52 mmHg, and after the surgery, the pressure reduced dramatically to 13.20 ± 1.42 mmHg. The difficulties associated with blebs are resolved on their own. After the operation, there was an improvement in visual acuity. The average values increased from 0.86 ± 0.15 before the surgery to 0.22 ± 0.26 on day 1, 0.20 ± 0.23 on day 7, 0.19 ± 0.23 on day 14, 0.18 ± 0.19 on day 30, and 0.18 ± 0.19 on day 45. A paired t-test demonstrated a statistically significant difference (p=0.02) in postoperative visual acuity between day 1 and day 45. The study's findings indicate that Mitomycin-C is efficacious in phacotrabeculectomy, resulting in decreased intraocular pressure and enhanced visual acuity, with no notable problems. The findings provide valuable insights into managing concurrent glaucoma and cataracts, presenting a viable strategy in tertiary care settings.
References
Agarwal, H. C., Sharma, T. K., Sihota, R., & Gulati, V. (2002). Cumulative effect of risk factors on short-term surgical success of mitomycin augmented trabeculectomy. Journal of Postgraduate Medicine, 48(2), 92–96.
Ben Simon, G. J., & Glovinsky, Y. (2006). Trabeculectomy with brief exposure to mitomycin C. Clinical & Experimental Ophthalmology, 34(8), 765–770. https://doi.org/10.1111/j.1442-9071.2006.01305.x
Bowman, R. J. C., Hay, A., Wood, M. L., & Murdoch, I. E. (2010). Combined cataract and trabeculectomy surgery for advanced glaucoma in East Africa; visual and intra-ocular pressure outcomes. Eye (London, England), 24(4), 573–577. https://doi.org/10.1038/eye.2009.132
Casson, R. J., & Salmon, J. F. (2001). Combined surgery in the treatment of patients with cataract and primary open-angle glaucoma. Journal of Cataract and Refractive Surgery, 27(11), 1854–1863. https://doi.org/10.1016/s0886-3350(01)01127-0
Chen, D. Z., Koh, V., Sng, C., Aquino, M. C., & Chew, P. (2015). Complications and outcomes of primary phacotrabeculectomy with mitomycin C in a multi-ethnic Asian population. PloS One, 10(3), e0118852. https://doi.org/10.1371/journal.pone.0118852
El Sayed, Y. M., Elhusseiny, A. M., Albalkini, A. S., El Sheikh, R. H., & Osman, M. A. (2019). Mitomycin C-augmented Phacotrabeculectomy Versus Phacoemulsification in Primary Angle-closure Glaucoma: A Randomized Controlled Study. Journal of Glaucoma, 28(10), 911–915. https://doi.org/10.1097/IJG.0000000000001345
Friedman, D. S., Jampel, H. D., Lubomski, L. H., Kempen, J. H., Quigley, H., Congdon, N., Levkovitch-Verbin, H., Robinson, K. A., & Bass, E. B. (2002). Surgical strategies for coexisting glaucoma and cataract: an evidence-based update. Ophthalmology, 109(10), 1902–1913. https://doi.org/10.1016/s0161-6420(02)01267-8
Graf, E. N., Müller, M., Gerlach, F., M Meyer, L., Philipp, S., Distelmaier, P., Klink, T., & Schönfeld, C.-L. (2019). Comparison of 2-year-results of mitomycin C-augmented trabeculectomy with or without cataract extraction in glaucoma patients. Canadian Journal of Ophthalmology. Journal Canadien d’ophtalmologie, 54(3), 347–354. https://doi.org/10.1016/j.jcjo.2018.07.006
Husain, R., Liang, S., Foster, P. J., Gazzard, G., Bunce, C., Chew, P. T. K., Oen, F. T. S., Khaw, P. T., Seah, S. K. L., & Aung, T. (2012). Cataract surgery after trabeculectomy: the effect on trabeculectomy function. Archives of Ophthalmology (Chicago, Ill. : 1960), 130(2), 165–170. https://doi.org/10.1001/archophthalmol.2011.329
Hyung, S. M., & Kim, S. K. (2001). Mid-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients. Korean Journal of Ophthalmology : KJO, 15(2), 98–106. https://doi.org/10.3341/kjo.2001.15.2.98
Kass, M. A., Heuer, D. K., Higginbotham, E. J., Johnson, C. A., Keltner, J. L., Miller, J. P., Parrish, R. K. 2nd, Wilson, M. R., & Gordon, M. O. (2002). The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Archives of Ophthalmology (Chicago, Ill. : 1960), 120(6), 701–730. https://doi.org/10.1001/archopht.120.6.701
Kastner, A., & King, A. J. (2020). Advanced glaucoma at diagnosis: current perspectives. Eye (London, England), 34(1), 116–128. https://doi.org/10.1038/s41433-019-0637-2
Khandelwal, R., Bijlani, M., Raje, D., & Rathi, A. (2019). Evaluating the efficacy of short duration Mitomycin C in safe surgery system trabeculectomy combined with cataract surgery. Clinical Ophthalmology (Auckland, N.Z.), 13, 849–857. https://doi.org/10.2147/OPTH.S192044
Khaw, P. T., Shah, P., & Elkington, A. R. (2004). Glaucoma--1: diagnosis. BMJ (Clinical Research Ed.), 328(7431), 97–99. https://doi.org/10.1136/bmj.328.7431.97
Medhi, J., Karmakar, M., Barman, A., Mondal, S., & Nag, A. (2023). Diabetic retinopathy stage detection using convolutional fine-tuned transfer Learning model. International Journal of Experimental Research and Review, 31(Spl Volume), 33-41. https://doi.org/10.52756/10.52756/ijerr.2023.v31spl.004
Kotrappa, R., Yakkundi, A., Khangavi, B., Meena, A., & Shah, D. (2016). The safety and efficacy of minimal dose of mitomycin C in trabeculectomy. Journal of the Scientific Society, 43, 135. https://doi.org/10.4103/0974-5009.190526
Sengupta, S., Pal, N., & Bhattacharyya, A. (2021). Synthesis of Coumarin Based Chemo-Sensors for the Detection of CN¯ Ions. International Journal of Experimental Research and Review, 25, 18-33. https://doi.org/10.52756/ijerr.2021.v25.003
Sihota, R., Angmo, D., Chandra, A., Gupta, V., Sharma, A., & Pandey, R. M. (2015). Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma. Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie, 253(7), 1153–1159. https://doi.org/10.1007/s00417-015-3028-9
Skuta, G. L., & Parrish, R. K. 2nd. (1987). Wound healing in glaucoma filtering surgery. Survey of Ophthalmology, 32(3), 149–170. https://doi.org/10.1016/0039-6257(87)90091-9
Veldman, E. & Greve, E. L. (1987). Glaucoma filtering surgery, a retrospective study of 300 operations. Doc Ophthalmol, 67(1-2),151-170.
Verges, C., Cazal, J., & Lavin, C. (2005). Surgical strategies in patients with cataract and glaucoma. Current Opinion in Ophthalmology, 16(1), 44–52. https://doi.org/10.1097/00055735-200502000-00008
Wilkins, M., Indar, A., & Wormald, R. (2005). Intra-operative mitomycin C for glaucoma surgery. The Cochrane Database of Systematic Reviews, 2005(4), CD002897. https://doi.org/10.1002/14651858.CD002897.pub2
Wishart, P. K. & Austin, M. W. (1993). Combined cataract extraction and trabeculectomy: phacoemulsification compared with extracapsular technique. Ophthalmic Surg., 24(12): 814-821.
Copyright (c) 2023 International Academic Publishing House (IAPH)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.